Construct: ORF ccsbBroadEn_11604

Construct Description:

Construct Type:
ORF
Other Identifiers:
ORF013395.1_s300c1, BRDN0000384968
DNA Barcode:
None
Epitope Tag:
None
Notes:
No stop codon in insert

Originally Annotated References:

Gene:
RABL2B (11158)

Vector Information:

Vector Backbone:
pDONR223
Pol II Cassette 1:
n/a
Pol II Cassette 2:
n/a
Selection Marker:
n/a
Visible Reporter:
n/a
Epitope Tag:
n/a

Current transcripts matched by this ORF:

Taxon Gene Symbol Description Transcript Nuc. Match %[?] Prot. Match %[?] Match Diffs[?]
1 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028559.2 85.3% 85.3% 298_348del
2 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003234.1 59.1% 45% (many diffs)
3 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354424.2 52.6% 43.6% (many diffs)
4 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306161.2 52.1% 43.3% (many diffs)
5 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354421.2 52.1% 43.3% (many diffs)
6 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354423.2 52.1% 43.3% (many diffs)
7 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003226.1 52.1% 43.3% (many diffs)
8 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354418.2 51.5% 40.9% (many diffs)
9 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354419.2 51.5% 40.9% (many diffs)
10 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003223.1 51.5% 40.9% (many diffs)
11 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354417.2 43.7% 43.7% (many diffs)
12 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130922.3 43.4% 43.4% 298_684del
13 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350005.2 43.4% 43.4% 298_684del
14 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350006.2 43.4% 43.4% 298_684del
15 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350007.2 43.4% 43.4% 298_684del
16 human 11158 RABL2B RAB, member of RAS oncogene... NM_007081.4 43.4% 43.4% 298_684del
17 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028556.1 43.4% 43.4% 298_684del
18 human 11158 RABL2B RAB, member of RAS oncogene... NM_001003789.3 43.2% 43.2% 298_687del
19 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130919.3 43.2% 43.2% 298_687del
20 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130920.3 43.2% 43.2% 298_687del
21 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130921.3 43.2% 43.2% 298_687del
22 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350003.2 43.2% 43.2% 298_687del
23 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350004.2 43.2% 43.2% 298_687del
24 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028552.1 43.2% 43.2% 298_687del
25 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028555.1 43.2% 43.2% 298_687del
26 human 11158 RABL2B RAB, member of RAS oncogene... XM_024452147.1 43.2% 43.2% 298_687del
27 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354416.2 42.9% 42.9% (many diffs)
28 human 11159 RABL2A RAB, member of RAS oncogene... NM_007082.5 42.9% 42.9% (many diffs)
29 human 11159 RABL2A RAB, member of RAS oncogene... NM_013412.4 42.9% 42.9% (many diffs)
30 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003220.1 42.9% 42.9% (many diffs)
31 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003222.1 42.9% 42.9% (many diffs)
32 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306158.2 42.7% 42.7% (many diffs)
33 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306159.2 42.7% 42.7% (many diffs)
34 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354412.2 42.7% 42.7% (many diffs)
35 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354413.2 42.7% 42.7% (many diffs)
36 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354414.2 42.7% 42.7% (many diffs)
37 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003213.1 42.7% 42.7% (many diffs)
38 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003214.1 42.7% 42.7% (many diffs)
39 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003215.1 42.7% 42.7% (many diffs)
40 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003216.1 42.7% 42.7% (many diffs)
41 human 11159 RABL2A RAB, member of RAS oncogene... XM_024452575.1 42.7% 42.7% (many diffs)
42 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028551.1 42.3% 42.3% 298_702del
43 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350016.2 42.1% 42.1% 298_705del
44 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350017.2 42.1% 42.1% 298_705del
45 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003212.1 41.8% 41.8% (many diffs)
46 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003210.1 41.7% 41.7% (many diffs)
47 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003211.1 41.7% 41.7% (many diffs)
48 human 11158 RABL2B RAB, member of RAS oncogene... NM_001130923.3 41.5% 41.5% 298_714del
49 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350013.2 41.5% 41.5% 298_714del
50 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350014.2 41.5% 41.5% 298_714del
51 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350015.2 41.5% 41.5% 298_714del
52 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028547.1 41.5% 41.5% 298_714del
53 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350008.2 41.4% 41.4% 298_717del
54 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350009.2 41.4% 41.4% 298_717del
55 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350010.2 41.4% 41.4% 298_717del
56 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350011.2 41.4% 41.4% 298_717del
57 human 11158 RABL2B RAB, member of RAS oncogene... NM_001350012.2 41.4% 41.4% 298_717del
58 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028543.1 41.4% 41.4% 298_717del
59 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028544.1 41.4% 41.4% 298_717del
60 human 11158 RABL2B RAB, member of RAS oncogene... XM_017028546.1 41.4% 41.4% 298_717del
61 human 11159 RABL2A RAB, member of RAS oncogene... NM_001306160.3 41.1% 41.1% (many diffs)
62 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354410.2 41.1% 41.1% (many diffs)
63 human 11159 RABL2A RAB, member of RAS oncogene... XM_024452573.1 41.1% 41.1% (many diffs)
64 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354405.2 41% 41% (many diffs)
65 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354406.2 41% 41% (many diffs)
66 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354407.2 41% 41% (many diffs)
67 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354408.2 41% 41% (many diffs)
68 human 11159 RABL2A RAB, member of RAS oncogene... NM_001354409.2 41% 41% (many diffs)
69 human 11159 RABL2A RAB, member of RAS oncogene... XM_006712208.3 41% 41% (many diffs)
70 human 11159 RABL2A RAB, member of RAS oncogene... XM_006712209.3 41% 41% (many diffs)
71 human 11159 RABL2A RAB, member of RAS oncogene... XM_011510509.2 41% 41% (many diffs)
72 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003203.1 41% 41% (many diffs)
73 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003204.1 41% 41% (many diffs)
74 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003205.1 41% 41% (many diffs)
75 human 11159 RABL2A RAB, member of RAS oncogene... XM_017003207.1 41% 41% (many diffs)
76 human 11159 RABL2A RAB, member of RAS oncogene... NR_148879.2 14.5% (many diffs)
77 human 11159 RABL2A RAB, member of RAS oncogene... NR_148882.2 14.4% (many diffs)
78 human 11159 RABL2A RAB, member of RAS oncogene... NR_148881.2 14.4% (many diffs)
79 human 11159 RABL2A RAB, member of RAS oncogene... NR_148880.2 13.3% (many diffs)
80 human 11159 RABL2A RAB, member of RAS oncogene... XR_002959036.1 11.7% (many diffs)
81 mouse 68708 Rabl2 RAB, member RAS oncogene fa... XM_006521326.3 38.4% 39.1% (many diffs)
82 mouse 68708 Rabl2 RAB, member RAS oncogene fa... NM_026817.3 38.2% 39% (many diffs)
83 mouse 68708 Rabl2 RAB, member RAS oncogene fa... XM_006521327.3 25.1% 27.3% (many diffs)
Download CSV

Sequence Information

Note: uppercase bases indicate empirically verified sequence.

ORF start:
66
ORF end:
363
ORF length:
297
Sequence:
1gttcgttgca acaaattgat gagcaatgct tttttataat gccaaCTTTG TACAAAAAAG
61TTGGCATGGC AGAAGACAAA ACCAAACCGA GTGAGTTGGA CCAAGGGAAG TATGATGCTG
121ATGACAACGT GAAGATCATC TGCCTGGGAG ACAGCGCAGT GGGCAAATCC AAACTCATGG
181AGAGATTTCT CATGGATGGC TTTCAGCCAC AGCAGCTGTC CACGTACGCC CTGACCCTGT
241ACAAGCACAC AGCCACGGTA GATGGAAGGA CCATCCTTGT GGACTTTTGG GACACGGCAG
301GCCAGGAGCG GTTCCAGAGC ATGCATGCCT CCTACTACCA CAAGGCCCAC GCCTGCATCA
361TGTGCCCAAC TTTCTTGTAC AAAGTtggca ttataagaaa gcattgctta tcaatttgtt
421gcaacgaac

Download FASTA (ORF) (Full)

GPP Web Portal Terms of Service

Effective Date: December 8, 2025
By using this site, you agree to our terms and conditions below.

Overview of Terms

The data made available on this website were generated for research purposes and are not intended for clinical or commercial uses. Commercial use (or other use for profit-making purposes) of the GPP Web Portal and its tools, is not permitted under these terms and may require a separate license agreement from Broad or its contributors. For more information, please contact partnering@broadinstitute.org.

The original data may be subject to rights claimed by third parties, including but not limited to, patent, copyright, other intellectual property rights, biodiversity-related access and benefit-sharing rights. It is the responsibility of users of Broad Institute services to ensure that their use of the data does not infringe any of the rights of such third parties.

Any questions or comments concerning these Terms of Use can be addressed to: legal@broadinstitute.org.

By accessing and viewing this GPP Web Portal, you agree to the following terms and conditions:

Attribution

You agree to acknowledge the Broad Institute (e.g., in publications, services or products) for any of your use of its online services, databases or software in accordance with good scientific practice. You agree to use the acknowledgment wording provided for the relevant tools as indicated on the FAQ for each tool.

Updating the Terms of Use

We reserve the right to update these Terms of Use at any time. When alterations are inevitable, we will attempt to give reasonable notice of any changes by placing a notice on our website, but you may wish to check each time you use the website. The date of the most recent revision will appear on this, the "GPP Web Portal Terms of Use" page. If you do not agree to these changes, please do not continue to use our online services. We will also make available an archived copy of the previous Terms of Use for comparison.

Indemnification and Disclaimer of Warranties

You are using this GPP Web Portal at your own risk, and you hereby agree to hold Broad and its contributors and their trustees, directors, officers, employees, and affiliated investigators harmless for any third party claims which may arise from your use of the GPP Web Portal, the tools available therein, or any portion thereof. Further, you agree to indemnify Broad, its contributors, and its and their trustees, directors, officers, employees, affiliated investigators, students, and affiliates for any loss, costs, claims, damages, or other liabilities arising from any unpermitted commercial or profit-making use you make of the GPP Web Portal. The GPP Web Portal is a research tool and is provided "as is". Broad does not represent that the GPP Web Portal is free of errors or bugs or suitable for any particular tasks.

ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS ARE DISCLAIMED. IN NO EVENT SHALL BROAD OR ITS CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THE GPP WEB PORTAL, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

Governing Law

The terms and conditions herein shall be construed, governed, interpreted, and applied in accordance with the internal laws of the Commonwealth of Massachusetts, U.S.A. Furthermore, by accessing, downloading, or using the Database, You consent to the personal jurisdiction of, and venue in, the state and federal courts within Massachusetts with respect to Your download or use of the Database.